Hardy J. Rideout

Academy of Athens — Greece

Medicine · Health Sciences

33h-index4.1kcitations67works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(43), Cellular transport and secretion(11), Ubiquitin and proteasome pathways(11), Cell death mechanisms and regulation(9), Lysosomal Storage Disorders Research(9)

Publications67 total

Extracellular Vesicle‐Mediated Delivery of Constrained Peptides Disrupts the Pathogenic Interaction of LRRK2‐FADD in Parkinson's Disease
Journal of Extracellular Biology·2026Open Access
Regulation between LRRK2 and PP2A signaling in cellular models of Parkinson’s disease
2025Open Access
Regulation of LRRK2 activity by metabolic stress and heavy metal exposure
Brain Research·2025Open Access
Disruption of the LRRK2‐FADD Interface Using Constrained Peptides
Peptide Science·2024· 1 citedOpen Access
Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk
Journal of Parkinson s Disease·2023Open Access
Perspective on the current state of the LRRK2 field
npj Parkinson s Disease·2023· 135 citedOpen Access
Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization
ACS Chemical Neuroscience·2023· 21 citedOpen Access
Longitudinal transcriptomic analysis of mouse sciatic nerve reveals pathways associated with age‐related muscle pathology
Journal of Cachexia Sarcopenia and Muscle·2023· 15 citedOpen Access
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
npj Parkinson s Disease·2022· 43 citedOpen Access
Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts
npj Parkinson s Disease·2022· 22 citedOpen Access
Editorial: LRRK2—Fifteen Years From Cloning to the Clinic
Frontiers in Neuroscience·2022· 1 citedOpen Access
Transcriptomic analysis of aging mouse sciatic nerve reveals early pathways leading to sarcopenia
2022· 1 citedOpen Access
Leucine rich repeat kinase 2 (<scp>LRRK2</scp>) peptide modulators: Recent advances and future directions
Peptide Science·2021
Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts
2021· 2 citedOpen Access
The activities of LRRK2 and GCase are positively correlated in clinical biospecimens and experimental models of Parkinson’s disease
2021· 2 citedOpen Access
Allosteric Inhibition of Parkinson’s-Linked LRRK2 by Constrained Peptides
ACS Chemical Biology·2021· 37 citedOpen Access
Defining (and blocking) neuronal death in Parkinson’s disease: Does it matter what we call it?
Brain Research·2021· 10 cited
The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease
Frontiers in Neuroscience·2020· 50 citedOpen Access
Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of <scp>Leucine‐Rich</scp> Repeat Kinase 2 <scp>G2019S</scp> Carriers: A Novel <scp>Enzyme‐Linked</scp> Immunosorbent Assay–Based Method
Movement Disorders·2020· 32 citedOpen Access
The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
Biomolecules·2020· 62 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Leonidas Stefanis(24), William T. Dauer(7), Isabelle Lang‐Rollin(7), Anna Memou(7), Kostas Vekrellis(5), Diane B. Ré(4), Εμμανουέλα Λεάνδρου(4), Katerina Melachroinou(4), Leonidas Stefanis(3), Qiaohong Wang(3), David S. Park(3), Lilian Petropoulou-Vathi(3), Maria Kedariti(3), Roy N. Alcalay(3), Michalis Kentros(3), Omar Jabado(3), Polytimi‐Eleni Valkimadi(3), Kristin E. Larsen(2), David Sulzer(2), Lloyd A. Greene(2)